Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
95.84
-0.44 (-0.45%)
Oct 19, 2026, 2:32 PM EDT - Market open
Insmed Market Cap
Insmed has a market cap or net worth of $20.93 billion as of October 19, 2026. It is the 1,150th most valuable company in the world and the 469th biggest in the United States. Its market cap has decreased by 40.27% in one year.
Market Cap
20.93B
Enterprise Value
20.51B
1-Year Change
-40.27%
Global Rank
Country Rank
#469 United States
Category
ChartMarket Cap Chart
Since June 1, 2000, Insmed's market cap has increased from $409.10M to $20.93B, an increase of 5,015.76%. That is a compound annual growth rate of 16.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 20.93B | -43.62% |
| Dec 31, 2025 | 37.12B | 200.52% |
| Dec 31, 2024 | 12.35B | 178.59% |
| Dec 29, 2023 | 4.43B | 63.79% |
| Dec 30, 2022 | 2.71B | -16.06% |
| Dec 31, 2021 | 3.22B | -4.92% |
| Dec 31, 2020 | 3.39B | 58.95% |
| Dec 31, 2019 | 2.13B | 110.95% |
| Dec 31, 2018 | 1.01B | -57.65% |
| Dec 29, 2017 | 2.39B | 191.73% |
| Dec 30, 2016 | 818.60M | -27.02% |
| Dec 31, 2015 | 1.12B | 46.00% |
| Dec 31, 2014 | 768.30M | 15.55% |
| Dec 31, 2013 | 664.90M | 217.07% |
| Dec 31, 2012 | 209.70M | 177.01% |
| Dec 30, 2011 | 75.70M | -7.91% |
| Dec 31, 2010 | 82.20M | -18.05% |
| Dec 31, 2009 | 100.30M | 75.35% |
| Dec 31, 2008 | 57.20M | -43.08% |
| Dec 31, 2007 | 100.50M | 13.95% |
| Dec 29, 2006 | 88.20M | -17.72% |
| Dec 30, 2005 | 107.20M | 26.86% |
| Dec 31, 2004 | 84.50M | -25.88% |
| Dec 31, 2003 | 114.00M | 665.10% |
| Dec 31, 2002 | 14.90M | -88.15% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 34.62B |
| Alnylam Pharmaceuticals | 31.48B |
| Roivant Sciences | 25.09B |
| Genmab | 23.57B |
| Incyte | 23.00B |
| BioNTech SE | 22.30B |
| Exelixis | 15.48B |
| Ascendis Pharma | 15.11B |